Global HEOR Strategy Lead: Payer Evidence & Value

UCB S.A.; Anderlecht; Hybride; EUR 120 000 - 165 000; Plein temps

Résumé du poste

UCB S.A. seeks an HEOR Strategy Lead to shape global payer evidence strategies across the product lifecycle. You will influence development programs and collaborate with Market Access, Real World Evidence, and Medical Affairs to ensure robust, payer-aligned evidence generation.

The role requires 8+ years in pharma, expertise in modelling and HTA submissions, and strong leadership for global, matrixed teams. Hybrid work in Brussels, with international collaboration.

Qualifications

• Master's degree or PhD in Health Economics, Market Access, Outcomes Research, Public Health, Epidemiology, Pharmacy, or related field.
• At least 8 years of experience in the pharmaceutical industry, including consultancy where relevant.
• Strong expertise in health economic modelling, outcomes research, and payer evidence generation.
• Experience supporting HTA submissions, reimbursement strategies, and access initiatives across key markets.
• Experience working in global or matrix organizations with cross-border exposure valued.
• Strong leadership, communication, stakeholder management, and strategic thinking skills.

Responsabilités

• Develop and continuously refine global HEOR and payer evidence strategies aligned with asset and market access objectives.
• Design and deliver key HEOR evidence generation activities, including cost-effectiveness models, budget impact models, systematic literature reviews, and health outcomes research.
• Develop asset value assessments and support economically justified pricing and value strategies.
• Build and communicate compelling economic value stories for assigned assets and indications.
• Influence clinical development programs to address payer and HTA requirements across EU markets.
• Represent HTA and payer perspectives within cross-functional evidence generation and development teams.
• Support the creation of global value dossiers and guide affiliate teams on reimbursement and access strategies.
• Partner with cross-functional stakeholders to execute studies strengthening payer decision-making.
• Integrate affiliate and market-specific payer requirements into global evidence generation plans.
• Contribute to scientific publications, congress presentations, external partnerships, and thought leadership.

Connaissances

HEOR

Strategic thinking

Leadership

Stakeholder management

Communication

Evidence generation

Formation

Master's degree or PhD in Health Economics or related field

Description du poste

UCB S.A. seeks an HEOR Strategy Lead to shape global payer evidence strategies across the product lifecycle. You will influence development programs and collaborate with Market Access, Real World Evidence, and Medical Affairs to ensure robust, payer-aligned evidence generation.

The role requires 8+ years in pharma, expertise in modelling and HTA submissions, and strong leadership for global, matrixed teams. Hybrid work in Brussels, with international collaboration.